Virtual care company LetsGetChecked has secured $150m in a series D financing round to boost its care capabilities.

Led by Casdin Capital, the funding round saw participation from CommonFund Capital, Illumina Ventures, Optum Ventures, Transformation Capital, HLM Venture Partners, Qiming Venture Partners USA, and professional golfer Rory Mcllroy through Symphony Ventures.

With the latest funding round, LetsGetChecked’s total capital raise has reached more than $260m.

The new capital will be used by LetsGetChecked to introduce care pathways, as well as 360-degree customer care journey to deliver remote care for patients with ailments and chronic conditions.

Care pathways are facilitated by LetsGetChecked’s core offerings such as telehealth services, pharmacy capabilities and at-home diagnostics. The investment will be mainly used for these core offerings.

To receive real-time guidance and diagnoses, consumers will have to connect with LetsGetChecked-affiliated medical professionals through asynchronous chat and video vis the firm’s app and web-enabled interface.

LetsGetChecked aims to introduce expanded virtual customer consultation capabilities such as asynchronous chat and video.

The firm intends to expand its pharmaceutical services with the addition of long-term care solutions for conditions such as cholesterol and thyroid management.

In addition, the firm will focus on strengthening its capabilities to deliver diagnostic test kits directly to customers for sample collection and processing using its own diagnostic laboratories and end-to-end model.

It plans to launch new test offerings this year.

LetsGetChecked founder and CEO Peter Foley said: “We are seeing unprecedented demand for at-home diagnostics and care as an alternative to traditional in-person medical visits, and we are expanding our offerings to include telehealth and treatment services to further help people live longer, happier lives.”

At present, LetsGetChecked offers customers access to over 100 validated at-home tests such as sexual health, cholesterol, diabetes, thyroid and coronavirus (Covid-19).

It also offers follow-up care via its telehealth and pharmacy offerings.